Pharma Pulse 3/4/25: A New Era for Faster, Smarter Clinical Trials, Educational Resources to Support Patients & more

Beyond the Horizon: A New Era for Faster, Smarter Clinical Trials

Current industry trends align with the need for improved, fit for purpose technology.

Educational Resources to Support Patients

Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.

AbbVie Enters Obesity Market With Up to $2.2 Billion Gubra Deal

AbbVie Inc. agreed to pay as much as $2.2 billion for a next-generation obesity drug from Danish biotech Gubra A/S, marking its entry into the hyper-competitive weight-loss market.

Tenovi and GenieMD Forge Transformative Partnership to Expand Access to Remote Care and Enhance Medication Adherence

GenieMD and Tenovi have joined forces to enhance access to care through transformative virtual care models. The collaboration debuts with the Tenovi Pillbox, empowering individuals managing chronic conditions and their caregivers with real-time medication adherence tracking from home.

Joseph (Joey) D'Angelo on LinkedIn

"Pharming" it out like a boss! Looking forward to ringing the bell with her soon!

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs